Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 111

    1.

    The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy.

    Van Roy N, De Preter K, Hoebeeck J, Van Maerken T, Pattyn F, Mestdagh P, Vermeulen J, Vandesompele J, Speleman F.

    Genome Med. 2009 Jul 27;1(7):74.

    PMID:
    19638189
    [PubMed]
    Free PMC Article
    2.

    Global genomic and RNA profiles for novel risk stratification of neuroblastoma.

    Ohira M, Nakagawara A.

    Cancer Sci. 2010 Nov;101(11):2295-301. doi: 10.1111/j.1349-7006.2010.01681.x. Review.

    PMID:
    20731666
    [PubMed - indexed for MEDLINE]
    3.

    Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.

    Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, Shue D, Seiser E, Jagannathan J, Shusterman S, Bansal M, Khazi D, Winter C, Okawa E, Grant G, Cnaan A, Zhao H, Cheung NK, Gerald W, London W, Matthay KK, Brodeur GM, Maris JM.

    Cancer Res. 2006 Jun 15;66(12):6050-62.

    PMID:
    16778177
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Neuroblastoma: biology and staging.

    Mueller S, Matthay KK.

    Curr Oncol Rep. 2009 Nov;11(6):431-8. Review.

    PMID:
    19840520
    [PubMed - indexed for MEDLINE]
    5.

    High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.

    Carén H, Erichsen J, Olsson L, Enerbäck C, Sjöberg RM, Abrahamsson J, Kogner P, Martinsson T.

    BMC Genomics. 2008 Jul 29;9:353.

    PMID:
    18664255
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Neuroblastoma epigenetics: from candidate gene approaches to genome-wide screenings.

    Decock A, Ongenaert M, Vandesompele J, Speleman F.

    Epigenetics. 2011 Aug 1;6(8):962-70. Epub 2011 Aug 1. Review.

    PMID:
    21725203
    [PubMed - indexed for MEDLINE]
    7.

    The biologic basis for neuroblastoma heterogeneity and risk stratification.

    Maris JM.

    Curr Opin Pediatr. 2005 Feb;17(1):7-13. Review.

    PMID:
    15659956
    [PubMed - indexed for MEDLINE]
    8.

    Genetic parameters of neuroblastomas.

    Westermann F, Schwab M.

    Cancer Lett. 2002 Oct 28;184(2):127-47. Review.

    PMID:
    12127685
    [PubMed - indexed for MEDLINE]
    9.

    FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.

    Spitz R, Hero B, Ernestus K, Berthold F.

    Med Pediatr Oncol. 2003 Jul;41(1):30-5.

    PMID:
    12764740
    [PubMed - indexed for MEDLINE]
    10.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    11.

    Genetic stratification of neuroblastoma for treatment tailoring.

    Jeison M, Yaniv I, Ash S.

    Future Oncol. 2011 Sep;7(9):1087-99. Review.

    PMID:
    21919696
    [PubMed - indexed for MEDLINE]
    12.

    Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.

    Mosse YP, Diskin SJ, Wasserman N, Rinaldi K, Attiyeh EF, Cole K, Jagannathan J, Bhambhani K, Winter C, Maris JM.

    Genes Chromosomes Cancer. 2007 Oct;46(10):936-49.

    PMID:
    17647283
    [PubMed - indexed for MEDLINE]
    13.

    Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.

    George RE, Attiyeh EF, Li S, Moreau LA, Neuberg D, Li C, Fox EA, Meyerson M, Diller L, Fortina P, Look AT, Maris JM.

    PLoS One. 2007 Feb 28;2(2):e255.

    PMID:
    17327916
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Genetics and genomics of neuroblastoma.

    Capasso M, Diskin SJ.

    Cancer Treat Res. 2010;155:65-84. Review.

    PMID:
    20517688
    [PubMed - indexed for MEDLINE]
    15.

    Alternative pathways of MYCN gene copy number increase in primary neuroblastoma tumors.

    Valent A, Guillaud-Bataille M, Farra C, Lozach F, Spengler B, Terrier-Lacombe MJ, Valteau-Couanet D, Danglot G, Lenoir GM, Brison O, Bénard J, Bernheim A.

    Cancer Genet Cytogenet. 2004 Aug;153(1):10-5.

    PMID:
    15325088
    [PubMed - indexed for MEDLINE]
    16.

    Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma.

    Alaminos M, Davalos V, Cheung NK, Gerald WL, Esteller M.

    J Natl Cancer Inst. 2004 Aug 18;96(16):1208-19.

    PMID:
    15316056
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.

    Spitz R, Betts DR, Simon T, Boensch M, Oestreich J, Niggli FK, Ernestus K, Berthold F, Hero B.

    Cancer Genet Cytogenet. 2006 May;167(1):51-6.

    PMID:
    16682287
    [PubMed - indexed for MEDLINE]
    18.

    [Genetic alterations in neuroblastoma and their usefulness for clinical management].

    Normand C, Michon J, Janoueix-Lerosey I, Delattre O, Schleiermacher G.

    Bull Cancer. 2011 May;98(5):477-88. Review. French.

    PMID:
    21609891
    [PubMed - indexed for MEDLINE]
    19.

    MicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics.

    Stallings RL.

    Curr Pharm Des. 2009;15(4):456-62. Review.

    PMID:
    19199973
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    Molecular pathogenesis of peripheral neuroblastic tumors.

    Janoueix-Lerosey I, Schleiermacher G, Delattre O.

    Oncogene. 2010 Mar 18;29(11):1566-79. Epub 2010 Jan 25. Review.

    PMID:
    20101209
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk